• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

OTC COVID-19/Influenza Test Approval Comes Too Late to Save Lucira Health

OTC COVID-19/Influenza Test Approval Comes Too Late to Save Lucira Health

by Glenn S. Demby | Mar 31, 2023 | Inside the Lab Industry-lir, Laboratory Industry Report

No company better embodies the vicissitudes of running a COVID-19-focused diagnostics business during the pandemic period than Lucira Health.

This content is for Paid Members only.
Login Register
FDA Breaks New Ground in COVID-19 & Concussion Blood Testing Approvals

FDA Breaks New Ground in COVID-19 & Concussion Blood Testing Approvals

by Glenn S. Demby | Mar 23, 2023 | Diagnostic Testing and Emerging Technologies, FDA-dtet

In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.

This content is for Paid Members only.
Login Register
Home-Based Flu Tests as Accurate as Rapid In-Clinic Options

Home-Based Flu Tests as Accurate as Rapid In-Clinic Options

by University of Washington School of Medicine | Mar 14, 2022 | Articles, News, Open Content

Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings, according to a recently published, peer-reviewed study. “Home tests are a valuable tool to support the management of influenza and other...

Influenza Testing: Study Finds Older Patients Are Under-Tested and Under-Diagnosed

by Glenn S. Demby | Feb 27, 2018 | National Lab Reporter, News-nir

...

This content is for Paid Members only.
Login Register

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com